Scientists from Trinity College Dublin have discovered that electrically stimulating macrophages—one of the immune systems key players—can reprogram them in such a way as to reduce inflammation and ...

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

Reprogram是一家肿瘤细胞重编程技术研发商，向肿瘤内注射mRNA 基因组合，直接在体内（in situ）把肿瘤细胞重编程为抗原呈递细胞（APC），把免疫抑制的肿瘤微环境变成免疫激活位点，触发全身抗肿瘤免疫反应，不依赖外源免疫细胞或广谱药物，让肿瘤 ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...